SYDNEY, May 14, 2026 /PRNewswire/ -- Cynosure Lutronic's XERF is a radiofrequency-based treatment designed to tighten and revitalise skin without the need for needles, numbing or downtime. Positioned as the world's first single-shot, multifrequency monopolar RF technology, XERF combines 6.78 MHz and 2 MHz frequencies to deliver energy at multiple tissue depths, targeting the surface, mid and structural layers of the skin.

The result is a treatment designed to support smoother, tighter and more rejuvenated-looking skin, while maintaining patient comfort through Wave Fit pulse technology and advanced integrated cryogen cooling.

The Australian launch is expected to attract strong interest across the medical aesthetic and beauty sectors, particularly as demand grows for treatments that can deliver visible results without the discomfort and recovery often associated with more intensive procedures.

Recently unveiled at Sydney's iconic Taronga Zoo, with views of the Harbour Bridge and Opera House, XERF's launch was aptly staged in a setting framed by some of the world's most celebrated structures; a nod to the device's focus on structural skin tightening. XERF's arrival also reflects a broader shift in the aesthetics market toward treatments that sit between skincare and more invasive interventions, giving patients options that are lower-disruption but still clinically driven. For clinics, that shift is also driven by demand for treatments that can be easily integrated into busy schedules while still delivering visible, clinically meaningful results.

Among the early adopters is Dr Dae Hwan Kwon, a Melbourne-trained cosmetic physician with a special interest in regenerative skin health and aesthetic harmony. After first learning about the technology in Korea and trialling it on himself, he introduced it into practice with a focus on lower-face tightening, jawline definition, neck rejuvenation and brow lifting.

Over time, Dr Kwon moved beyond the standard protocol and began customising treatments based on face shape and clinical need, a shift he says has delivered strong patient satisfaction.

"What really struck me was that it was significantly less painful than other radiofrequency machines, and that was a major advantage," Dr Kwon said.

"XERF works especially well for people who want lower-face tightening, a more sculpted jawline and tighter neck lines. It can also be highly effective for brow lifting, and when I combine it with jaw contouring treatments, it can deliver a better result with a longer-lasting effect."

A similar experience has been reported by Dr Siew Tuck Wah, a leading Singapore doctor in the field of non-invasive medical aesthetics, who has used XERF for about a year and treated around 100 patients. With a clinic already equipped with multiple energy-based technologies, Dr Siew said XERF stood out because it offered a genuinely new approach, particularly in terms of comfort and adaptability.

Rather than applying a one-size-fits-all treatment, Dr Siew said the device allows practitioners to tailor depth and mode according to facial structure, including whether a patient has a heavier face, more subcutaneous fat, or milder signs of laxity. In his experience, XERF has performed well across a broader range of patients than many practitioners might typically expect from radiofrequency, including older patients and those with heavier jowls.

"What surprised me was that even older patients and those with heavier jowls responded to XERF," Dr Siew said. "They saw lifting, improvement in skin quality, more definition of the jawline and improvement in the upper neck."

He also highlighted the device's developing versatility, including smaller treatment tips designed for delicate areas such as the skin around the eyes.

"What XERF has shown me is that it can be very comfortable to treat. Patients find it more comfortable than other radiofrequency devices, and that has translated into very high patient satisfaction," Dr Siew said.

"Patients often see lifting within two weeks of treatment, and the results are long lasting, more than three months."

The XERF system also features an innovative spider-pattern tip designed to reduce edge effects and support more controlled energy delivery, with the aim of increasing both treatment efficacy and patient safety. Its shorter treatment times may also allow clinics to treat more patients in a day compared with existing similar skin-tightening technologies.

For clinics in Australia and New Zealand, the arrival of XERF comes at a time when non-surgical aesthetic treatments continue to grow, particularly among patients seeking visible results without interrupting their daily lives.

As practitioners increasingly look for technologies that combine performance, efficiency and patient comfort, XERF is entering the market with strong momentum and a growing reputation among early adopters.

"If you're new to XERF and considering adding it to your clinical practice, my advice is please go ahead, because it has changed my practice and brought a whole new dimension to skin tightening for me," Dr Siew said.

About Cynosure Lutronic

Cynosure Lutronic was formed following the merger of Cynosure and Lutronic in 2024 which creates a global medical aesthetics organization built on more than 60 years of combined innovation in energy-based technologies.

Cynosure Lutronic develops and commercializes energy-based devices across a wide range of aesthetic indications with direct operations in North America, Europe, and Asia-Pacific, and product distribution in approximately 130 countries.

SINGAPORE, April 23, 2026 /PRNewswire/ -- Patients in Singapore now have access to XERF^™, Cynosure Lutronic's Structural Skin Tightening device, at leading aesthetic clinics across the country, following the announcement of XERF^™ winning at the SBR Technology Excellence Awards 2026. 

XERF^™ delivers a treatment that can remodel the structure of tissue to restore firmness from within. It delivers all the skin-tightening, collagen-boosting power of radiofrequency (RF) energy, without numbing or needles. Just visible results, backed by science and designed for comfort. Unlike conventional RF treatments, XERF^™ delivers RF energy deeper into the skin, reaching the shallow, middle, and deep layers where real change begins.

XERF™ has been carefully designed with comfort in mind. The treatment feels warm and comfortable, thanks to Integrated Cryogen Delivery (ICD) that cools the skin's surface during each pulse, and Wave Fit™ pulse technology, which balances energy delivery to maximize comfort.

"XERF™ represents a genuine advancement in non-invasive Structural Skin Tightening offering patients in Singapore access to a treatment designed for precision, comfort and zero downtime, backed by the consistent and impressive results that providers across the region are already seeing." said Shannon Wooldridge, APAC Marketing Director for Cynosure Lutronic.

XERF^™ is now offered at selected aesthetic clinics across Singapore. Patients can locate their nearest provider via the clinic finder at xerf.sg/clinics, and follow @xerf.sg on Instagram for treatment information and featured clinics.

About Cynosure Lutronic
Cynosure Lutronic is a global leader in medical aesthetic and energy-based device technology, delivering clinically proven solutions for aesthetic practitioners and patients across the Asia-Pacific region and beyond.

The XERF™ RF system is intended as a non-invasive dermatological aesthetic treatment device with indications for wrinkles and rhytids. Product availability, approved indications, and regulatory clearances may vary by country or region. Patients should consult with a qualified healthcare professional to determine if XERF™ is right for them. Cynosure Lutronic does not diagnose or treat medical conditions, prescribe treatment protocols, or provide medical advice.

SINGAPORE, Feb. 27, 2026 /PRNewswire/ -- Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and Japan. This marks a significant expansion of the company's clinically approved laser portfolio across two of Asia's most highly regulated aesthetic markets. 

"The approval enables the introduction of a single, integrated dual wavelength laser platform designed to support multiple treatment indications and diverse patient profiles and is also reflective of Cynosure Lutronic's growing strength across the Asia Pacific region" said Nadav Tomer, CEO of Cynosure Lutronic.

China: Regulatory Approval 

In China, Clarity II (marketed as CLARITY II ICD) has received regulatory approval for use in medical institutions as of 12^th February 2026.  

• Product Name: Clarity II ICD 
• Approved Indications: 
• 755nm laser – approved to reduce wrinkles on the cheeks 
• 1064nm laser – approved to reduce unwanted body hair 

The approval authorizes the use of a single integrated platform across multiple treatment applications within regulated clinical settings of China. 

Japan: Regulatory Approval 

In Japan, Clarity II has received regulatory clearance as of 9^th January 2026 for use in medical aesthetic practices. 

• Product Name: Clarity II 
• Approved Indication: 
• Alexandrite 755nm / Nd:YAG 1064nm approved for Long-term hair reduction 

The clearance confirms compliance with Japan's stringent medical device regulatory requirements for laser-based aesthetic treatments. 

Clinical and Operational Context 

In both China and Japan, medical aesthetic practices are operating under increasingly rigorous regulatory and clinical expectations, with heightened emphasis on treatment precision, indication-specific use, and safety. 

The regulatory approvals of Clarity II reflect growing demand for laser platforms that consolidate multiple clinically validated applications within a single system, while maintaining strict control over energy delivery and treatment parameters. In China, approval across both hair removal and wrinkle treatment applications enables practitioners to address multiple patient needs with one versatile platform. In Japan, clearance of the latest-generation system reinforces confidence in technological refinement and output consistency within a highly regulated clinical environment. 

Together, these approvals position Clarity II as a platform aligned with the evolving standards of advanced aesthetic practice in Asia compliance, and clinical versatility are increasingly critical. 

About Clarity II 

Clarity II is a dual-wavelength long-pulse laser system designed to support a range of aesthetic medical applications. The platform integrates: 

• Alexandrite 755nm and Nd:YAG 1064nm wavelengths in a single system 
• Large spot sizes to support efficient treatment of broad areas 
• Short pulse duration capabilities for refined and precision-based treatments 
• A fiber-free system architecture designed to simplify operation and maintenance 
• Automated delivery features intended to support consistency and practitioner workflow 

About Cynosure Lutronic 

Cynosure Lutronic was formed following the merger of Cynosure and Lutronic in 2024 which creates a global medical aesthetics organization built on more than 60 years of combined innovation in energy-based technologies. 

Cynosure Lutronic develops and commercializes energy-based devices across a wide range of aesthetic indications with direct operations in North America, Europe, and Asia-Pacific, and product distribution in approximately 130 countries. 

LinkedIn | Instagram